Gregory Braden to Kidney Transplantation
This is a "connection" page, showing publications Gregory Braden has written about Kidney Transplantation.
Connection Strength
0.629
-
Singh G, Hsia-Lin A, Skiest D, Germain M, O'Shea M, Braden G. Successful kidney transplantation from a hepatitis B surface antigen-positive donor to an antigen-negative recipient using a novel vaccination regimen. Am J Kidney Dis. 2013 Apr; 61(4):608-11.
Score: 0.350
-
Lipkowitz GS, Madden RL, Kurbanov A, Mulhern JG, O'Shea MH, Germain MJ, Freeman J, Braden GL. Transplantation and 2-year follow-up of kidneys procured from a cadaver donor with a history of lupus nephritis. Transplantation. 2000 Mar 27; 69(6):1221-4.
Score: 0.145
-
Benedetto B, Madden R, Kurbanov A, Braden G, Freeman J, Lipkowitz GS. Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction. Am J Kidney Dis. 2001 May; 37(5):E37.
Score: 0.039
-
Madden RL, Mulhern JG, Benedetto BJ, O'Shea MH, Germain MJ, Braden GL, O'Shaughnessy J, Lipkowitz GS. Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients. Transpl Int. 2000; 13(5):344-50.
Score: 0.036
-
Lipkowitz GS, Madden RL, Mulhern J, Braden G, O'Shea M, O'Shaughnessy J, Nash S, Kurbanov A, Freeman J, Rennke H, Germain M. Long-term maintenance of therapeutic cyclosporine levels leads to optimal graft survival without evidence of chronic nephrotoxicity. Transpl Int. 1999; 12(3):202-7.
Score: 0.033
-
Mulhern JG, Lipkowitz GS, Braden GL, Madden RL, O'Shea MH, Harvilchuck H, Guarnera JM, Germain MJ. Association of post-renal transplant erythrocytosis and microalbuminuria: response to angiotensin-converting enzyme inhibition. Am J Nephrol. 1995; 15(4):318-22.
Score: 0.025